LAM-003

· OrphAI Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAM-003, covering 2024-05-03 to 2024-05-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LAM-003 in Patients With Acute Myeloid Leukemia [Phase 1]